Category Matches
- 0.1 mg
- 1 g
- 1 kg
- 1 kit
- 1 L
- 1 mg
- 1 ml
- 1 MU
- 1 Plate
- 1 µg
- 10 g
- 10 mg
- 10 ml
- 10 µg
- 100 g
- 100 mg
- 100 mh
- 100 ml
- 100 Tests
- 100 µg
- 100-200 Tests
- 1000 g
- 100g
- 11β-HSD Inhibitor
- 125 mg
- 125 Tests
- 1mg
- 2-BHA
- 2BHA
- 5 x 100 µg
- 5-a-reductase Inhibitors
- 5-bromo-2'-deoxyuridine
- 5-HT1 Receptors - Analgesics
- 5-HT1 Receptors - Antidepressant
- 5-HT1 Receptors - Antipsychotic
- 5-HT1 Receptors - Anxiolytic
- 5-HT1 Receptors - Cognition Enhancing
- 5-HT1 Receptors - Hypnotics
- 5-HT1 Receptors - Sedatives
- 5-HT7 Receptors - Analgesics
- 5-HT7 Receptors - Antidepressant
- 5-HT7 Receptors - Antipsychotic
- 5-HT7 Receptors - Anxiolytic
- 5-HT7 Receptors - Cognition Enhancing
- 5-HT7 Receptors - Sedatives
- 5-Lipoxygenase Inhibitors
- 5-α-Reductase Inhibitors
- 50-100 Tests
- a-Glucosidase Inhibitors
- Abl
- acalabrutinib
- ACE Inhibitors
- Acetyl-CoA Carboxylase Inhibitor
- ACP-196
- ACP196
- adu-s100
- adus100
- afatinib
- alvocidib
- Amphibian peptides and Hormones
- anabasine
- anatabine
- Androgen Synthesis Inhibitors
- Angiotensin II Inhibitors
- anti-tuberculosis
- Antibacterial
- antibacterial
- Antibiotic
- Antidiabetic
- antimicrobial
- Antimicrobial - Peptides
- Antimicrobial Peptides - Microbiology
- Antimicrobial Peptides - Natural Products
- Antimicrobial Peptides - Others
- Antithrombotic
- antituberculosis
- Apitolisib
- arbovirus
- Aromatase Inhibitors - Anticancer
- Aromatase Inhibitors - Immunology
- AT-7519
- AT7519
- AZ-5104
- AZ5104
- AZD-1152
- AZD-1152-HQPA
- AZD-1208
- AZD-8186
- AZD-9291
- B02
- BACE
- BACE1
- Bacteriostatics
- Bafilomycin
- baricitinib
- BAY1816032
- BAY80-6946
- BChE - Cognition Enhancing
- BChE - Neurodegenerative Diseases
- Bcl-2
- Bcl-xl
- Bedaquiline
- benzylguanine
- Beta Blockers - Anti-anginal
- Beta-Adrenergic Agonists
- Beta-Adrenergic Receptor Antagonists
- beta-zearalanol
- beta-zearalenol
- bexarotene
- BHA
- bifonazole
- Biguanides
- Biochemicals
- Bisphosphonates
- BIX01294
- Blog Post
- BML-275
- BMP
- BMS-754807
- boceprevir
- Bone Disease Treatments
- bortezomib
- BRD
- brigatinib
- BTK
- BUB1
- budesonide
- BYL719
- Ca2+ Channel Blockers - Anti-anginal
- Ca2+ Channel Blockers - Antihypertensive
- Ca2+ Channel Blockers - Vasodilatory
- cabozantinib
- Cancer Biology
- Cannabinoid Receptors - Analgesics
- Cannabinoid Receptors - Antidepressant
- Cannabinoid Receptors - Anxiolytic
- Cannabinoid Receptors - Sedatives
- capecitabine
- carbamazepine
- carbapenems
- CCK Release Inhibitors
- CCT-245737
- Cell Membrane Modifiers
- CEP-28122
- CGK733
- chemicals for COVID-19 research
- CHIR99021
- Chk1/2
- Class I (Na+ Channel Blocker)
- Class II (Beta Blocker)
- Class III (K+ Channel Blocker)
- Class IV (Ca2+ Channel Blocker)
- cochliobolin
- copanlisib
- COVID-19
- covid-19
- COVID-19 chemicals
- COVID-19 compounds
- COX-1 - Analgesics
- Coxibs
- crizotinib
- cucurbitane
- CYP17A1 Inhibitors
- D1 Receptors - Analgesics
- D1 Receptors - Anesthetic
- D1 Receptors - Antidepressant
- D1 Receptors - Antipsychotic
- D1 Receptors - Anxiolytic
- D1 Receptors - Cognition Enhancing
- D1 Receptors - Neurodegenerative Diseases
- D1 Receptors - Sedatives
- Dabrafenib
- dabrafenib
- Daunorubicin
- destruxin B
- Dihydrofolate Reductase Inhibitors
- dinaciclib
- DNA and RNA Synthesis Inhibitors
- DNA Strand Break-Inducing Agents
- docetaxel impurity B
- Dopamine Receptor Inhibitors
- DOT1L Histone Methyltransferase
- doxorubicin
- DPP-4 Inhibitors
- ebastine
- Eicosanoid Inhibitors
- eidd-1931
- EIDD-2801
- EIDD2801
- eIF2B - Cognition Enhancing
- eIF2B - Neurodegenerative Diseases
- elbasvir
- ensartinib
- entrectinib
- Ergosterol Inhibitors
- Estrogen Receptor Inhibitors
- Factor Xa Inhibitors
- febuxostat
- Furans - Other nucleic acid inhibitors
- GABA
- GABA - Analgesics
- GABA - Anesthetic
- GABA - Antidepressant
- GABA - Antiepileptics and Anticonvulsants
- GABA - Antipsychotic
- GABA - Anxiolytic
- GABA - Cognition Enhancing
- GABA - Neurodegenerative Diseases
- GABA - Sedatives
- Gastric Inhibitory Peptide
- GBR-12935
- GDC-0941
- GDC-0973
- gefitinib
- gemcitabine
- gilteritinib
- GLP-1 Agonists
- GpIIb/IIIa
- GW-5074
- GW-788388
- HDAC inhibitor
- herbimycin
- HEXIM1
- HIF-1
- HMG-CoA Reductase Inhibitors (Statins)
- Hs578T
- Hs578Ts(i)8
- HSP70
- IGF-1R
- imatinib
- Inhibitors of other enzymes
- Integrase Inhibitors
- irbesartan
- ITF-2357
- JQ-1
- JQ-1
- K+ ATP Channel Blockers
- K252b
- kashin-beck
- Kinesin Inhibitors
- KNL1
- larotrectinib
- lestaurtinib
- lomeguatrib
- LOXO-195
- loxo195
- M2 Protein Inhibitors
- masitinib
- Mast Cell Stabilizers
- mereletinib
- Metabolic and GI Pathology
- Microbiology
- microbiome
- Microtubule Polymerization/Depolymerization Inhibitors
- monobactams
- Muscarininc Acetylcholine Receptor Inhibitors
- mycobacteria
- NCCT Inhibitors (Thiazide/Thiazide-like diuretics)
- nelarabine
- neratinib
- Neuraminidase Inhibitors
- NF-kB
- nilotinib
- Nitroimidazoles - Antibacterial
- NKCC1 Inhibitors (Loop Diuretics)
- non-tuberculous mycobacteria
- NSAIDs: COX-1 Inhibitors
- NSAIDs: COX-2 Inhibitors
- odontoblast
- olaparib
- olmutinib
- ophiobolin A
- osimertinib
- Other Nucleic Acid Inhibitors
- Others - Antibacterial
- Others - Antidiabetic
- Others - Antithrombotic
- Others - Cell Membrane Modifiers
- Others - Ergosterol Inhibitors
- Others - Other nucleic acid inhibitors
- OTX-015
- oxcarbazepine
- p110
- p110alpha
- P2Y12
- PDK1
- PF-07321332
- Pictrelisib
- Pim-1
- Pim1
- PKC412
- Platinum-based Agents
- Ponatinib
- ponatinib
- PPAR Agonists (Fibrates)
- prexasertib
- Prostaglandin D Synthase Inhibitors
- Protease Inhibitors
- Protein synthesis Inhibitors
- Proton Pump Inhibitors
- PTEFb
- quizartinib
- Rac1
- RAD51
- rated-1
- Renin Inhibitors
- Reverse Transcriptase Inhibitors
- Ribavirin
- Ribonucleotide Reductase
- RN-1734
- ROS1
- Ruxolitinib
- salbutamol
- Sapanisertib
- SB-203580
- SB-431542
- selitrectinib
- ser910
- Serine/Threonine Kinase Inhibitors
- Serotonin (5-HT3) Receptor Inhibitors
- simurosertib
- sofosbuvir
- sorafenib
- SRp75
- su9516
- substantia nigra
- sulbactam
- T315i
- TAK-931
- taselisib
- tazobactam
- tebuconazole
- Thrombin Inhibitors
- Thromboxane Receptor Antagonists
- Topoisomerase Inhibitors
- Triple-negative breast cancer
- tuberculosis
- tuberculosis
- Tubulin Inhibitors
- Tyrosine Kinase Inhibitors
- UNC0064-12
- uprosertib
- variable
- VE821
- vemurafenib
- vinblastine
- vinorelbine
- Viral Fusion and Entry Inhibitors
- vitamin B9
- voglibose
- wc_update_product_lookup_tables
- Website Updates
- woocommerce-db-updates
- α1-adrenergic Receptor Antagonists - Antihypertensive
- α1-adrenergic Receptor Antagonists - Vasodilatory
- β-Glucan Synthase Inhibitors (echinocandins)
- β-lactamase inhibitors
Product Matches
Product ID
Name
Description
Purity
- Six New Products for the New YearLKT Labs continues to expand its catalog with six new compounds for the new year...
- Oxytocin Innovations and an FDA-approved Peptide DatabasePeptides and proteins as therapeutics have the advantage over other drugs of usi...
- Catalog RequestThe 2016-18 LKT Labs catalog contains close to 3,000 small molecules and peptide...
- Terms and ConditionsLKT Laboratories Inc. is focused on the production and distribution of high puri...
- Product FlyersBelow are many of the promotional flyers, you can select the one you want or you...
- Bulk Quote RequestLKT Labs offers discounting for bulk orders. We frequently provide small molecul...